Blood biologic markers of stroke: Improved management, reduced cost?

被引：11

作者：

Baird A.E. ^{[1
]}

机构：

[1] Stroke Neuroscience Unit, NINDS/NIH, Bethesda, MD 20892-1294

来源：

Current Atherosclerosis Reports | 2006年 / 8卷 / 4期

关键词：

Ischemic Stroke; Stroke Risk; Chronic Granulomatous Disease; Stroke Recurrence; Systolic Blood Pressure Level;

D O I：

10.1007/s11883-006-0003-2

中图分类号：

学科分类号：

摘要：

Identifying blood biomarkers may be of particular value in neurologic disorders such as stroke because of the difficulty in directly studying the brain and its blood vessels. Markers of brain injury, inflammation, excitotoxicity, and oxidative damage have been evaluated for their value in stroke diagnosis, treatment, and management, but none have proved to be sensitive or specific enough for routine clinical use. However, new cellular and molecular profiling approaches using the peripheral blood offer the potential for identifying panels of genes and proteins by increasing specificity while maintaining sensitivity. Furthermore, the first biomarker for predicting stroke risk associated with atherosclerosis (lipoprotein-associated phospholipase A2) was recently approved by the United States Food and Drug Administration. The ultimate aim for stroke biomarkers is to develop rapid, easy to use, widely available, and inexpensive diagnostic tests that can be used in the clinic and in clinical trials. Copyright © 2006 by Current Science Inc.

引用

页码：267 / 275

页数：8

共 50 条

[21]

Norris J.W., Hachinski V.C., Myers M.G., Et al., Serum cardiac enzymes in stroke, Stroke, 10, pp. 548-553, (1979)

[22]

Persson L., Hardemark H.G., Gustafsson J., Et al., S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system, Stroke, 18, pp. 911-918, (1987)

[23]

Fassbender K., Schmidt R., Schreiner A., Et al., Leakage of brain-originated proteins in peripheral blood: Temporal profile and diagnostic value in early ischemic stroke, J Neurol Sci, 148, pp. 101-105, (1997)

[24]

Sharp F.R., Lu A., Tang Y., Millhorn D.E., Multiple molecular penumbras after focal cerebral ischemia, J Cereb Blood Flow Metab, 20, pp. 1011-1032, (2000)

[25]

Onteniente B., Rasika S., Benchoua A., Guegan C., Molecular pathways in cerebral ischemia: Cues to novel therapeutic strategies, Mol Neurobiol, 27, pp. 33-72, (2003)

[26]

Weinstein P.R., Hong S., Sharp F.R., Molecular identification of the ischemic penumbra, Stroke, 35, SUPPL. 1, pp. 2666-2670, (2004)

[27]

Castillo J., Rodriguez I., Biochemical changes and inflammatory response as markers for brain ischaemia: Molecular markers of diagnostic utility and prognosis in human clinical practice, Cerebrovasc Dis, 17, SUPPL., pp. 17-18, (2004)

[28]

Cherubini A., Ruggiero C., Polidori M.C., Mecocci P., Potential markers of oxidative stress in stroke, Free Radic Biol Med, 39, pp. 841-852, (2005)

[29]

Vila N., Castillo J., Davalos A., Chamorro A., Proinflammatory cytokines and early neurological worsening in ischemic stroke, Stroke, 31, pp. 2325-2329, (2000)

[30]

Castellanos M., Leira R., Serena J., Et al., Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke, Stroke, 34, pp. 40-46, (2003)

← 1 2 3 4 5 →